Skip to main
AZTA

Azenta (AZTA) Stock Forecast & Price Target

Azenta (AZTA) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Azenta is positioned well within the life sciences market, offering a range of solutions for sample management and analysis needs. Despite a revenue and EPS miss for FY26, the company has provided strong guidance with expectations of 3-5% organic revenue growth and +300 bps adjusted EBITDA margin expansion. The company's focus on both Sample Management Solutions and Multiomics segments, as well as potential upside drivers such as M&A and faster outsourcing, support a positive outlook on the company's growth potential.

Bears say

Azenta is facing challenges with weak growth in its Multiomics segment and constrained capital demand for its services, leading to margin deleveraging and missed consensus estimates. While the company has a long-range plan for revenue and margin improvement, execution risk and potential competition could hinder their progress. With a lowered FY26 revenue outlook and an adjusted EBITDA margin that missed consensus, the stock may be facing a bottom as downside risks are limited by the company's balance sheet and FCF profile. However, potential upside drivers, such as a recovery in C&I de-stocking and cross-selling opportunities, could lead to a better performance for the stock in the future.

Azenta (AZTA) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Azenta (AZTA) Forecast

Analysts have given Azenta (AZTA) a Buy based on their latest research and market trends.

According to 5 analysts, Azenta (AZTA) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Azenta (AZTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.